Update to previous article: ‘Flakka’ designer drug sweeping the nation… | original source article HERE
Police chief William Southerd sees another use of video and audio recordings taken by police wearing body cameras. In the case of a Christopher, Illinois man who died in June after taking an emerging drug known as flakka, both legislators and would-be users need to see the recording. Within minutes of police arriving at the man’s home, he dies after a violent rage brought on by the drug. “I think every state representative or state senator ought to sit down and watch that video” Southerd said. “I’ve never seen anything like that.” Southerd is working on showing the video in schools. The man is seen disrobed, so the chief would want to block genitals and the man’s face. He also would not show the death, he said. Southerd said he first began hearing of flakka in the past couple of months.
According to an April ’emerging trends’ report from the National Institute on Drug Abuse (NIDA), the “dangerous” drug is “surging in Florida and is also being reported in other parts of the country.” The drug is a synthetic cathinone called alphapyrrolidinopentiophenone (alpha-PVP) similar to so-called bath salts, NIDA says. It takes the form of a white or pink, foul-smelling crystal that can be eaten, snorted, injected or vaporized in an e-cigarette or similar device. “Vaporizing, which sends the drug very quickly into the bloodstream, may make it particularly easy to overdose” NIDA reports. The drug like similar drugs, can cause a condition known as excited delirium that involves hyperstimulation, paranoia, and hallucinations that can lead to violent aggression and self-injury, NIDA says. It has been linked to deaths by suicide as well as heart attacks. It can also dangerously raise body temperatures and lead to kidney damage or failure. There have been reports that body temperatures can rapidly skyrocket to 106 degrees. View full article
Nick Mariano (10 August 2015) New deadly drug hits Southern Illinois [online newspaper]. Retrieved from http://ow.ly/QHypC